(33-1). Biopharmaceutical Engineering
(33-2). Nanoparticles in Biopharmaceuticals
(33-3). Clinical Trials on Biopharmaceutical Products
(33-4). Drug Disposition & Pharmacokinetics
(33-5). Bioavailability/Bioequivalence on Biopharmaceutical Products
(33-6). Formulation of Biotech Products
(33-7). Novel Approaches in Biopharmaceutics
(33-8). Pharmaceutical Engineering and Drug Delivery Systems
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Comparative study of endo-?-1,4-mannanases from novel bacterial strains for the production of galactomanno-oligosaccharides
Shruti Saini, National Agri-food and Bio-manufacturing Institute, India
Title : Engineering Sf9 host cells with AcMNPV genes to control baculovirus infection dynamics and heterologous gene expression
Tamer Z Salem, Zewail City of Science and Technology, Egypt